24小时热门版块排行榜    

查看: 494  |  回复: 0

药渡

银虫 (小有名气)


[交流] 有钱买股,没钱研发

夏季美国最大的头条之一就是NantKwest公司首次公开募股就完成2亿美元的市值,公司市值达25亿美元,接下来的日子,股价一直下滑,目前,已经下滑三分之一,该公司没有注入钱到研发,而是用5000万美元回购股票。



   NantKwest ($NK), an oncology biotech in Patrick Soon-Shiong's constellation of companies, made headlines over the summer when it pulled off a $200 million IPO that valued it at more than $2.5 billion. But the company's share value has slipped by nearly a third in the ensuing months, and instead of pouring money into developing its self-described breakthrough medicines, management has taken the uncommon tack of laying out $50 million to buy back stock.

   NantKwest's 'growth prospects and long-term strategy are not reflected in the company's current stock price,' Soon-Shiong said in a statement, and its buyback program 'demonstrates our confidence in the strength of our business, our strong conviction in our long-term growth prospects and our commitment to delivering shareholder value.'

   The move is an unusual one for loss-taking, research-focused biotech companies, which generally use their IPO proceeds to invest in R&D in hopes of coming up with clinical data that might boost their market value. That $50 million figure well outstrips the $3.9 million NantKwest spent on research in the third quarter. Cellectis ($CLLS), which has a similar market cap, spends nearly three times that per quarter, as does Adaptimmune ($ADAP), a U.K. oncology biotech with a valuation about half the size of NantKwest's.

   But Soon-Shiong has never been much for biotech convention. The entrepreneur, who made a fortune selling Abraxis Bioscience to Celgene ($CELG) for $2.9 billion, operates more than about a dozen companies under his NantWorks umbrella. Most are focused on oncology, and each deals almost exclusively with its sibling companies.

   NantCell, developing a once-failed Amgen ($AMGN) treatment for cancer, has raised more than $175 million and teamed up with frequent Soon-Shiong partner Sorrento Therapeutics ($SRNE) in immuno-oncology. Then there's NantiBody, a joint venture with Sorrento; NantPharma, at work on a next-generation version of Celgene's Abraxane; NantBioScience, developing nanoparticle cancer treatments; and NantHealth, a tech firm offering what Soon-Shiong calls 'the Google of genome mapping.'

[ Last edited by 凌宇雷池 on 2015-11-16 at 18:07 ]
回复此楼
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 药渡 的主题更新
普通表情 龙 兔 虎 猫 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[硕博家园] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +4 XJXMuRjD7cK7 2026-11-13 4/200 2026-11-16 11:28 by K7HMGGdOpylw
[公派出国] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +4 uKOSCocCb6Fm 2026-11-13 4/200 2026-11-16 10:44 by K7HMGGdOpylw
[考研] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +3 SX5mJmPWDfOO 2026-11-13 3/150 2026-11-15 07:56 by xSrQNSSjcgoX
[论文投稿] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +4 XJXMuRjD7cK7 2026-11-13 4/200 2026-11-15 07:01 by xSrQNSSjcgoX
[考研] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +3 uKOSCocCb6Fm 2026-11-12 8/400 2026-11-15 02:26 by xSrQNSSjcgoX
[论文投稿] 售一区SCI文章T0P,我:8O.551.O54,科目全,可十急 +4 uKOSCocCb6Fm 2026-11-12 10/500 2026-11-15 02:15 by xSrQNSSjcgoX
[硕博家园] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +4 G2rhSvqvhNzl 2026-11-10 6/300 2026-11-15 00:27 by Equinoxhua
[考研] 售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急 +5 G2rhSvqvhNzl 2026-11-10 7/350 2026-11-14 21:58 by Equinoxhua
[论文投稿] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +4 gRND4NVAZ8VG 2026-11-11 5/250 2026-11-13 11:15 by Equinoxhua
[教师之家] 售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急 +6 czAiolzR0IJC 2026-11-10 6/300 2026-11-12 16:55 by zzy933268
[硕博家园] 售SCI一区T0P文章,我:8.O55.1.O.54,科目全,可十急 +4 cdqGD6ftHmbl 2026-11-11 4/200 2026-11-12 12:26 by ECLTXnJnRSXf
[公派出国] 售SCI一区T0P文章,我:8.O.55.1.O.54,科目齐全,可+急 +3 Z7qfCsdIiD1T 2026-11-10 7/350 2026-11-12 11:31 by HajghKOMynmz
[考博] 售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急 +4 czAiolzR0IJC 2026-11-10 7/350 2026-11-12 11:11 by HajghKOMynmz
[教师之家] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +4 czAiolzR0IJC 2026-11-10 7/350 2026-11-12 11:00 by HajghKOMynmz
[考博] 售SCI一区T0P文章,我:8.O.55.1.O.54,科目齐全,可+急 +3 G2rhSvqvhNzl 2026-11-10 5/250 2026-11-12 10:49 by HajghKOMynmz
[教师之家] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +4 G2rhSvqvhNzl 2026-11-10 6/300 2026-11-12 10:38 by HajghKOMynmz
[硕博家园] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +5 G2rhSvqvhNzl 2026-11-10 6/300 2026-11-12 10:30 by HajghKOMynmz
[考研] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +5 C6CRn66RYYXS 2026-11-10 7/350 2026-11-12 10:16 by HajghKOMynmz
[基金申请] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +3 TgvkbZZl9tqB 2026-11-11 5/250 2026-11-12 08:15 by HajghKOMynmz
[论文投稿] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +3 cdqGD6ftHmbl 2026-11-11 3/150 2026-11-12 07:53 by HajghKOMynmz
信息提示
请填处理意见